Created at Source Raw Value Validated value
Dec. 10, 2021, 2 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Randomized clinical trial for treatment of COVID-19 with chloroquine and placebo versus chloroquine and colchicine.Intervention chloroquine - hydroxychloroquine sulfate 400 mg bid for 1 or 2 (if body weight greater than 80 kg) days; followed by 400 mg daily until 10 days of treatment.Intervention colchicine - colchicine 0;5 mg tid for 5 days; followed by 0;5 mg bid for 5 days. If body weight greater than 80 kg; a loading dose of 1 mg will be used.Chloroquine and placebo experimental group: 30 subjects with moderate or severe forms of COVID-19 will receive the intervention chloroquine and placebo according to the scheme: 1 tablet every 8 hours for 5 days; followed by 1 tablet every 12 hours for 5 days.Experimental group chloroquine and colchicine: 30 subjects with moderate or severe forms of COVID-19 will receive the interventions chloroquine and colchicine.;E02.319", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 279, "treatment_name": "Chloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1455, "treatment_name": "Chloroquine+colchicine", "treatment_type": "Antimalarials+metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}]

Oct. 7, 2021, 9:30 a.m. oms

[]

Dec. 15, 2020, 2:47 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Randomized clinical trial for treatment of COVID-19 with chloroquine and placebo versus chloroquine and colchicine.Intervention chloroquine - hydroxychloroquine sulfate 400 mg bid for 1 or 2 (if body weight greater than 80 kg) days; followed by 400 mg daily until 10 days of treatment.Intervention colchicine - colchicine 0;5 mg tid for 5 days; followed by 0;5 mg bid for 5 days. If body weight greater than 80 kg; a loading dose of 1 mg will be used.Chloroquine and placebo experimental group: 30 subjects with moderate or severe forms of COVID-19 will receive the intervention chloroquine and placebo according to the scheme: 1 tablet every 8 hours for 5 days; followed by 1 tablet every 12 hours for 5 days.Experimental group chloroquine and colchicine: 30 subjects with moderate or severe forms of COVID-19 will receive the interventions chloroquine and colchicine.;Drug;E02.319", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Randomized clinical trial for treatment of COVID-19 with chloroquine and placebo versus chloroquine and colchicine.Intervention chloroquine - hydroxychloroquine sulfate 400 mg bid for 1 or 2 (if body weight greater than 80 kg) days; followed by 400 mg daily until 10 days of treatment.Intervention colchicine - colchicine 0;5 mg tid for 5 days; followed by 0;5 mg bid for 5 days. If body weight greater than 80 kg; a loading dose of 1 mg will be used.Chloroquine and placebo experimental group: 30 subjects with moderate or severe forms of COVID-19 will receive the intervention chloroquine and placebo according to the scheme: 1 tablet every 8 hours for 5 days; followed by 1 tablet every 12 hours for 5 days.Experimental group chloroquine and colchicine: 30 subjects with moderate or severe forms of COVID-19 will receive the interventions chloroquine and colchicine.;Drug;Drug Therapy", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]